https://www.selleckchem.com/products/xl177a.html After that, we get low dimensional embedding representations of drugdisease pairs by using topological features and singular value decomposition. Finally, a Random Forest classifier is trained to do the prediction. To train a more reasonable model, we select out some reliable negative samples based on the k-step neighbors relationships between drugs and diseases. Compared with some state-of-the-art methods, we use less information but achieve better or comparable performance. Meanwhile, our strategy for selecting reliable negative samples can improve the performances of these methods. Case studies have further shown the practicality of our method in discovering novel drug-disease associations.Due to technological advances the quality and availability of biological data has increased dramatically in the last decade. Analysing protein-protein interaction networks (PPINs) in an integrated way, together with subcellular compartment data, provides such biological context, helps to fill in the gaps between a single type of biological data and genes causing diseases and can identify novel genes related to disease. In this study, we present BCCGD, a method for integrating subcellular localization data with PPINs that detects breast cancer candidate genes in protein complexes. We achieve this by defining the significance of the compartment, constructing edge-weighted PPINs, finding protein complexes with a non-negative matrix factorization approach, generating disease-specific networks based on the known disease genes, prioritizing disease candidate genes with a WDC method. As a case study, we investigate the breast cancer but the techniques described here are applicable to other disorders. For the top genes scored by BCCGD approach, we utilize the literature retrieving method to test the correlations of them with the breast cancer. The results show that BCCGD discover some novel breast cancer candidate genes which are valuabl